findmyKOL

Katherine McGowan, MD

Basic profile

Infectious Disease

ORCIDNone on fileNPI
RegionBoston, MA · NortheastSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Katherine McGowan is an Infectious Disease physician. OpenAlex indexes 20 publications with 456 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
20publications

Distinct works indexed by OpenAlex.

456citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1153 Centre Street
Suite 4950 Faulkner Hospital
Boston, MA 02130

Telephone

617-522-4943

Registry record last updated 7 Mar 2023.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    34.2%
    Statin10%
    Atorvastatin Calcium69%Rosuvastatin Calcium18%Simvastatin13%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)7.5%
    Losartan Potassium55%Irbesartan45%
    Part D16 patients

    + 7 more classes in this area

  • Nervous system

    23.6%
    Benzodiazepine7%
    Lorazepam72%Diazepam28%
    Part D<11 patients
    Opioid Agonist5.1%
    Oxycodone-Acetaminophen39%Tramadol Hcl30%Oxycodone Hcl18%Morphine Sulfate12%
    Part D<11 patients

    + 6 more classes in this area

  • Anti-infectives

    21.1%
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor2.7%
    Triumeq70%Descovy30%
    Part D<11 patients
    Short-acting sulfonamides2.1%
    Sulfamethoxazole-Trimethoprim100%
    Part D12 patients

    + 13 more classes in this area

Where care is delivered (Part B)51.2% facility · 48.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”